Constellation Energy Corporation Common Stock reports $4.49 EPS, highlights strategic growth and sustainability amid favorable market conditions and regulatory progress
CGX achieves strong first quarter 2026 results, driven by blockbuster films and premium experiences, with 17.3% attendance growth and record box office revenue.
OLA Conference Call
The GEO Group, Inc. reports Q1 revenue decline amid margin pressures, yet demand remains robust in core markets with positive long-term outlook.
Atlanta Braves Holdings, Inc. Series C Common Stock sees revenue surge to $72M in Q1 2026, driven by strong team performance and Braves Vision rollout.
Telos Corporation Common Stock delivers 56% revenue growth and 16.5% adjusted EBITDA margin while reaffirming cautious full-year guidance and accelerating share buybacks.
SharpLink Gaming Ltd. Ordinary Shares achieves $12.1 million in Q1 revenue, driven by ETH treasury strategy and increasing institutional demand for Ethereum.
FS KKR Capital Corp. Common Stock shares insights on $150 million tender offer and $300 million buyback to drive long-term shareholder value amidst NAV challenges.
Certara, Inc. Common Stock reports mixed Q1 results; strategic AI investments and divestiture aim to drive future growth and operational efficiency.
Target Hospitality Corp. Common Stock secures $2 billion in multiyear contracts, driving Q1 revenue to $73 million and raising 2026 guidance amid strategic transformation.
Bicara Therapeutics Inc. Common Stock showcases strong Phase 1B results and discusses accelerated approval path for Physera ahead of ASCO 2026.
Uniti Group Inc. Common Stock reports solid first quarter as fiber revenue surges 26% year over year, with optimistic outlook for 2026 growth targets.
monday.com Ltd. Ordinary Shares achieves 24% revenue growth in Q1, driven by AI initiatives and strategic acquisition to enhance work platform capabilities.
Village Farms International, Inc. Common Shares reports 27% sales increase and strong profitability outlook driven by EU GMP compliance and expanded production capacity.
CEVA Inc. exceeds Q1 2026 revenue forecasts with 11% growth, strong licensing wins, and optimistic outlook for AI and connectivity markets.
Liquidia Corporation Common Stock achieves 44% sequential growth in Q1 2026 net product sales, with strong profitability and confidence in future revenue targets.
Heron Therapeutics, Inc. sees 22% demand growth for Zinrelef and maintains 2026 guidance amid temporary revenue pressures.
Exagen Inc. Common Stock achieves 12% revenue growth with improved profitability metrics; Q1 revenue reaches $17.3 million, reaffirming annual guidance of $70 to $73 million.
Cronos Group Inc. Common Share achieves record Q1 revenue of $45.2 million, driven by growth in international markets and plans for Canatellar acquisition.
Cronos Group Inc. Common Share reports 40% revenue growth, strong market share gains, and plans for strategic acquisition as industry dynamics evolve.